However, the activation of PPAR-γ in nonalcoholic fatty liver disease (NAFLD) mitigates hepatic lipid accumulation by enhancing fatty acid oxidation and reducing inflammatory responses. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.